ArticleInternational journal of clinical and experimental pathology2019
Clinical relevance of PET/CT in patients with newly diagnosed multiple myeloma.
Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- 18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?BMC medical imaging · 2022Article
- The Value of Diffuse Splenic and HepaticContrast media & molecular imaging · 2022Article
- 11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCurrently, the prognosis of standardized uptake value still has no consensus. We evaluated the role of the maximum standardized uptake value (SUV
methodsA total of 123 previously untreated, newly diagnosed patients were enrolled in this study, who were diagnosed at the Tianjin Medical University Cancer Institute and Hospital between September 2008 and February 2018. All patients with available PET/CT information at diagnosis were analyzed.
resultsWe found that no clinical characteristics were significantly different between the pathological fracture groups. However, laboratory findings including elevated creatinine and anemia at diagnosis corresponded to osteolytic lesions at baseline PET/CT (elevated creatinine, P = 0.024; anemia, P = 0.025). Compared to SUV
conclusionWe confirm the prognostic value of EMD, as detected by PET/CT, in newly diagnosed multiple myeloma patients. Therefore, the presence of EMD in newly diagnosed MM tends to be more important than the SUV
Indexed as
Identifiers
31933868PMC6945085W3006239410What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.